Biopharma Stock Updates - 12/11/20 | GILD, BTNX, IPHA...

Data Updates:

$GILD (+0.5) - New Data From Phase 3 ASCENT Trial

http://investors.gilead.com/news-releases/news-release-details/gilead-advances-oncology-portfolio-new-data-phase-3-ascent-trial


$PFE & $BNTX (-1.17) – ADCOM voted in favor of emergency use Covid vaccine

https://biontechse.gcs-web.com/news-releases/news-release-details/pfizer-and-biontech-receive-fda-advisory-committee-vote

$IPHA (-18.66) – Returns US and EU Lumoxiti commercialization rights to AstraZeneca

https://investors.innate-pharma.com/news-releases/news-release-details/innate-pharma-return-us-and-eu-lumoxiti-commercialization-rights


$XERS (+11.74) – Positive CHMP Opinion for OGLUO

https://investors.xerispharma.com/news-releases/news-release-details/xeris-pharmaceuticals-receives-positive-chmp-opinion-ogluotm-its


$GALT (-0.76) – Present at 4th Annual Digital NASH summit on December 17, 2020

https://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-inc-present-4th-annual-digital-nash-summit


$ODT (-1.25) – Positive Results of CONTESSA

https://ir.odonate.com/press-releases/2020-12-11-positive-results-of-contessa--a-phase-3-study-of-tesetaxel-in-patients-with-metastatic-breast-cancer--presented-at-the-2020-san-antonio-breast-cancer-symposium--sabcs--34efcaba-1739-4df6-9d83-e80207e193ea


Financial Updates:

$FMTX (+1.49) – Priced offering at $42.25/share

https://ir.formatherapeutics.com/news-releases/news-release-details/forma-therapeutics-announces-pricing-public-offering

$PTGX (-0.04) – Pricing of $100 Million Public Offering of Common Stock

https://investors.protagonist-inc.com/news-releases/news-release-details/protagonist-therapeutics-inc-announces-pricing-100-million


$SLDB (+51.62) – $90 Million Private Placement

https://investors.solidbio.com/news-releases/news-release-details/solid-biosciences-announces-90-million-private-placement


$KURA (+2.34) – Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

https://ir.kuraoncology.com/news-releases/news-release-details/kura-oncology-announces-closing-public-offering-and-full-2


$ALBO (-3.04) – Inducement Grant under Nasdaq Listing Rules 5635(c)(4)

https://ir.albireopharma.com/news-releases/news-release-details/albireo-reports-inducement-grant-under-nasdaq-listing-rule-0


$SNDX (-3.84) – Closing of Public Offering and Exercise in Full

http://ir.syndax.com/news-releases/news-release-details/syndax-announces-closing-public-offering-and-exercise-full


$PBYI (+1.17) – Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

https://investor.pumabiotechnology.com/news-releases/news-details/2020/Puma-Biotechnology-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635c4-d25b9528e/default.aspx

0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE